018765440

ALLISON INSTITUTE

---

September 21, 2022

Trademark Summary

The trademark ALLISON INSTITUTE was filed by The Board of Regents of the University of Texas System, a U.S. corporation (the "Applicant"). The application was published for oppositions on December 13, 2022, and received one opposition filed on March 13, 2023 by Capernaum Limited on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by FRKelly and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued March 13, 2023

The application was filed in Danish, and Danish was also language of all opposition proceedings (English was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on March 4, 2024.

---

Goods And Services

• The mark was filed in class 35 with following description of goods:
  
  1. Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease
  2. Collection and management of medical and scientific data in the field of medical and scientific research
  3. All the foregoing offered in relation to a cancer treatment or cancer research facility.
• The mark was filed in class 41 with following description of goods:
  
  1. Educational services, namely, conducting programs, seminars, lectures and workshops in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management
  2. Educational services, namely, developing and disseminating educational materials for others in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management
  3. Training courses concerning research and development in the fields of cancer, autoimmune diseases, immunobiology and immunotherapy
  4. All the foregoing offered in relation to a cancer treatment or cancer research facility.
• The mark was filed in class 42 with following description of goods:
  
  1. Medical research services
  2. Research, development, technical design, testing, consulting and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology
  3. Research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products
  4. Research services in the field of immune repertoire analysis and the genome
  5. Scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology
  6. Biological research
  7. Laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering
  8. Medical laboratory services
  9. Providing information on medical and scientific research in the field of immunobiology and immunotherapy
  10. Medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy
  11. Compiling data for research purposes in the field of medical science and medical consultancy
  12. Medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology.
• The mark was filed in class 44 with following description of goods:
  
  1. Medical and pharmaceutical services
  2. Medical and pharmaceutical services relating to cancer
  3. Immunobiology and immunotherapy medical services
  4. Medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, medical counseling
  5. Medical consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, and patient care management
  6. Providing medical information
  7. Providing health information in the field of immunobiology, immunotherapy, oncology and diseases
  8. Providing a web site featuring medical information
  9. Providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases
  10. Providing medical information, consultancy and advisory services
  11. Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
  12. Medical services, namely, medical diagnostic testing, monitoring and reporting services
  13. Providing information on health care and cancer treatment
  14. Medical services, namely, treatment in the field of oncology and related health problems and diseases
  15. Providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment
  16. Medical analysis services, namely, analysis of tumors, cancer or equivalent medical conditions.